Related Articles
Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: Potential prognostic marker and target for tumourigenicity-suppression
Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental therapy for prostate cancer in mouse xenografts
Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate
Qianliening capsule treats benign prostatic hyperplasia via induction of prostatic cell apoptosis
CYP3A4 promoter variant is associated with prostate cancer risk in men with benign prostate hyperplasia